FDA 官方药品与生物制品信息·AI 评分32
FDA 发布 GDUFA Type II API DMF 缴费收据报告
GDUFA Type II API DMF Payment Receipts Report
AI 导读
FDA 发布 GDUFA Type II 原料药 DMF 缴费收据报告,按收到月份和财年汇总月度缴费笔数。报告显示 FY 2023 至 FY 2026 合计分别为 385、263、370 和 303 笔,并注明数字可能因退款或其他缴费问题变动。
正文 · 原文
The DMF Payments Received table summarizes total monthly counts of GDUFA Type II Active Pharmaceutical Ingredient (API) Drug Master File (DMF) payments according to the month and the fiscal year in which they were received by the Agency. The numbers are subject to change due to refunds or other payment issues.
DMF Payments Received
| Month | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|
| Oct | 14 | 8 | 27 | - |
| Nov | 21 | 21 | 22 | 22 |
| Dec | 32 | 28 | 32 | 29 |
| Jan | 33 | 28 | 30 | 22 |
| Feb | 28 | 24 | 20 | 17 |
| Mar | 31 | 24 | 32 | 30 |
| Apr | 17 | 16 | 31 | 27 |
| May | 22 | 14 | 26 | 15 |
| June | 15 | 14 | 15 | 27 |
| July | 27 | 33 | 34 | 39 |
| Aug | 42 | 29 | 21 | 19 |
| Sept | 103 | 24 | 80 | 54 |
| Grand Total | 385 | 263 | 370 | 303 |
来源:FDA 官方药品与生物制品信息 · fda.gov